NCT01167231View on ClinicalTrials.gov

Prevention of Postprandial Hyperglycemia by Acarbose May be a Promising Therapeutic Strategy for Reducing the Increased Risk for Cardiovascular Disease

CompletedOBSERVATIONAL

Enrollment

3,310

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

June 30, 2008

Conditions

Diabetes Mellitus

Interventions

DRUG

Acarbose (Glucobay, BAYG5421)

Patients treated with acarbose tablets under the real-life setting. Dosing regimen customised to the needs of each participating patient according to the investigators assessment

Trial Locations (1)

Unknown

Many Locations